NS-3, a TRH-analog, reverses memory disruption by stimulating cholinergic and noradrenergic systems

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 2, 1996, Pages 391-399

  Ogasawara, Takashi ^a   Itoh, Yoshinori ^a   Tamura, Masaru ^a   Ukai, Yojiro ^a   Yoshikuni, Yoshiaki ^a   Kimura, Kiyoshi ^a  

^a NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

amnesia; DSP4; NS 3 (CG3703); nucleus basalis magnocellularis (NBM); passive avoidance response; rat

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; BRAIN MONOAMINE; MONOAMINE; MONTIRELIN; NEUROTOXIN; PHYSOSTIGMINE; PROTIRELIN DERIVATIVE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MAGNOCELLULAR NUCLEUS; MALE; MEMORY; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENERGIC SYSTEM; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0030044856     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02039-X     Document Type: Article

References (55)

1. Alpern, H. P.; Marriott, J. G. Short-term memory: Facilitation and disruption with cholinergic agents. Physiol. Behav. 11:571-575; 1973.
2. Altman, H. J.; Crosland, R. D.; Jenden, D. J.; Berman, R. F. Further characterizations of the nature of the behavioral and neurochemical effects of lesions of the nucleus basalis of Meynert in the rat. Neurobiol. Aging 6:125-130; 1985.
3. Anlezark, G. M.; Crow, T. J.; Greenway, A. P. Impaired learning and decreased cortical norepinephrine after bilateral locus coeruleus lesions. Science 181:682-684; 1973.
4. Archer, T.; Jonsson G.; Ross, S. B. A parametric study of the effects of noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurons in the CNS of the rat. Br. J. Pharmacol. 82:249-257; 1984.
5. Archer, T.; Ögren, S. O.; Johansson, G.; Ross, S. B. DSP4-induced two-way active avoidance impairment in rat: Involvement of central and peripheral noradrenatine depletion. Psychopharmacology (Berlin) 76:303-309; 1982.
6. Bassiri, R.; Utiger, R. D. Serum inactivation of the immunological and biological activity of thyrotropin-releasing hormone (TRH). Endocrinology 91:657-664; 1972.
7. Bauer, K. Thyroliberin analogues as competitive inhibitors of thyroliberin degradation by brain enzymes. Hoppe-Seyler's Z. Physiol. Chem. 360:1126; 1979.
8. Berman, R. F.; Crosland, R. D.; Jenden, D. J.; Altman, H. J. Persisting behavioral and neurochemical deficits in rats following lesions of the basal forebrain. Pharmacol. Biochem. Behav. 29: 581-586; 1987.
9. Burt, D. R.; Snyder, S. H. Thyrotropin releasing hormone (TRH): Apparent receptor binding in rat brain membranes. Brain Res. 93:309-328; 1975.
10. Cumin, R.; Bandle, E. F.; Gamzu, E.; Haefely, W. E. Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents. Psychopharmacology (Berlin) 78:104-111; 1982.
11. Decker, M. W.; Gallagher, M. Scopolamine-disruption of radial arm maze performance: Modification by noradrenergic depletion. Brain Res. 417:59-69; 1987.
12. Dunnett, S. B. Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats. Psychopharmacology (Berlin) 87:357-363; 1985.
13. Durkin, T. P.; Toumane, A. Septo-hippocampal and nBM-cortical cholinergic neurons exhibit differential time-courses of activation as a function of both type and duration of spatial memory testing in mice. Behav. Brain Res. 50:43-52; 1992.
14. Flicker, C.; Dean, R. L.; Watkins, D. L.; Fisher, S. K.; Bartus, R. T. Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat. Pharmacol. Biochem. Behav. 18:973-981; 1983.
15. Flohé, L.; Bauer, K.; Friderichs, E.; Günzler, W. A.; Hennies, H. H.; Herrling, S.; Lagler, F.; Ötting, F.; Schwertner, E. Biological effects of degradation-stabilized TRH analogues. In: Griffiths, E. C.; Bennett, G. W., eds. Thyrotropin-releasing hormone. New York: Raven Press; 1983:327-340.
16. Friderichs, E.; Schwertner, E.; Herrling, S.; Gunzler, W. A.; Flohé, L. Activity of thyroliberin analogs with a modified pyroglutamyl residue on the central nervous system. Hoppe-Seyler's Z. Physiol. Chem. 360:1146; 1979.
17. Friedman, E.; Lerer, B.; Kuster, J. Loss of cholinergic neurons in the rat neocortex produces deficits in passive avoidance learning. Pharmacol. Biochem. Behav. 19:309-312; 1983.
18. Glick, S. D.; Zimmerberg, B. Amnesic effects of scopolamine. Behav. Biol. 7:245-254; 1972.
19. 3H] dopa in various regions of the brain. J. Neurochem. 13:655-669; 1966.
20. Haga, T.; Noda, H. Choline uptake systems of rat brain synaptosomes. Biochem. Biophys. Acta 291:564-575; 1973.
21. Haroutunian, V.; Kanof, P. D.; Davis, K. L. Pharmacological alleviation of cholinergic lesion induced memory deficits in rats. Life Sci. 37:945-952; 1985.
22. Haroutunian, V.; Kanof, P. D.; Tsuboyama, G.; Davis, K. L. Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats. Brain Res. 507:261-266; 1990.
23. Hepler, D. J.; Olton, D. S.; Wenk, G. L.; Coyle, J. T. Lesions in nucleus basalis magnocellularis and medial septal area of rats produce qualitatively similar memory impairments. J. Neurosci. 5:866-873; 1985.
24. Hepler, D. J.; Wenk, G. L.; Cribbs, B. L.; Olton, D. S.; Coyle, J. T. Memory impairments following basal forebrain lesions. Brain Res. 346:8-14; 1985.
25. Hichens, M. A comparison of thyrotropin-releasing hormone with analogs: Influence of disposition upon pharmacology. Drug Metabol. Rev. 14:77-98; 1983.
26. Hökfelt, T.; Fuxe, K.; Johansson, O.; Jeffcoate, S.; White, N. Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Eur. J. Pharmacol. 34:389-392; 1975.
27. Itoh, Y.; Ogasawara, T.; Mushiroi, T.; Yamazaki, A.; Ukai, Y.; Kimura, K. Effect of NS-3, a thyrotropin-releasing hormone analog, on in vivo acetylcholine release in rat brain: Regional differences and its sites of action. J. Pharmacol. Exp. Ther. 271:884-890; 1994.
28. Itoh, Y.; Ogasawara, T.; Yamazaki, A.; Ukai, Y.; Miura, A.; Kimura, K. Enhancement of noradrenaline release from rat frontal cortex by thyrotropin releasing hormone and its analog, (3R,6R)-6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamide, as studied by intracerebral microdialysis. J. Pharmacol. Exp. Ther. 268:255-261; 1994.
29. Johanston, M. V.; McKinney, M.; Coyle, J. T. Neocortical cholinergic innervation: A description of extrinsic and intrinsic components in the rat. Exp. Brain Res. 43:159-172; 1981.
30. Khan, A.; Lai, H.; Ukai, Y.; Mirolo, M. H. NS-3, a TRH-analog, reverses repeated ECS-induced deficits in water-maze performance in the rat. Pharmacol. Biochem. Behav. 47:477-481; 1994.
31. Knigge, K. M.; Schock, D. Characteristics of the plasma TRH-degrading enzyme. Neuroendocrinology 19:277-287; 1975.
32. König, J. F. R.; Klippel, R. A. The rat brain: A stereotaxic atlas of the forebrain and lower parts of the brain stem. Huntington, NY: R. E. Krieger Publishing; reprint 1970.
33. Lacaille, J. C.; Harley, C. The action of norepinephrine in the dentate gyrus: Beta-mediated facilitation of evoked potentials in vitro. Brain Res. 358:210-220; 1985.
34. LoConte, G.; Bartolini, L.; Casamenti, F.; Marconcini-Pepeu, I.; Pepeu, G. Lesions of cholinergic forebrain nuclei: Changes in avoidance behavior and scopolamine actions. Pharmacol. Biochem. Behav. 17:933-937; 1982.
35. Metcalf, G. Regulatory peptides as a source of new drugs-The clinical prospects for analogues of TRH which are resistant to metabolic degradation. Brain Res. Rev. 4:389-408; 1982.
36. M'Harzi, M.; Jarrard, L. E. Strategy selection in a task with spatial and nonspatial components: Effects of fimbria-fornix lesions in rats. Behav. Neural Biol. 58:171-179; 1992.
37. Miyamoto, M.; Shintani, M.; Nagaoka, A.; Nagawa, Y. Lesioning of the rat basal forebrain leads to memory impairments in passive and active avoidance tasks. Brain Res. 328:97-104; 1985.
38. Miyamoto, M.; Kato, J.; Narumi, S.; Nagaoka, A. Characteristics of memory impairment following lesioning of the basal forebrain and medial septal nucleus in rats. Brain Res. 419:19-31; 1987.
39. Ogasawara, T.; Nakagawa, Y.; Ukai, Y,; Tamura, M.; Kimura, K. NS-3 (CG3703), a TRH-analog, ameliorates scopolamine-induced memory disruption in rats. Pharmacol. Biochem. Behav. 51:929-934; 1995.
40. Ogasawara, T.; Ukai, Y.; Tamura, M.; Taniguchi, N.; Kimura, K.; Sato, A. Effects of NS-3, an analogue of thyrotropin-releasing hormone, on the central nervous system. Biomed. Res. 14:317-328; 1993.
41. Ogasawara, T.; Ukai, Y.; Tamura, M.; Kimura, K. NS-3 (CG3703), an analogue of thyrotropin-releasing hormone, ameliorates cognitive impairment in rats, Pharmacol. Biochem. Behav. 50:499-503; 1995.
42. Oliver, C.; Eskay, R. L.; Ben-Jonathan, N.; Portar, J. C. Distribution and concentration of TRH in the rat brain. Endocrinology 95:540-546; 1974.
43. Pazos, A.; Corts, R.; Palacios, J. M. Thyrotropin releasing hormone receptor binding sites: Autoradiographic distribution in the rat and guinea pig brain. J. Neurochem. 45:1448-1463; 1985.
44. Sahgal, A.; Keith, A. B.; Lloyd, S.; Kerwin, J. M.; Perry, E. K.; Edwardson, J. A. Memory following cholinergic (NBM) and noradrenergic (DNAB) lesions made singly or in combination: Potentiation of disruption by scopolamine. Pharmacol. Biochem. Behav. 37:597-605; 1990.
45. Santucci, A. C.; Kanof, P. D.; Haroutunian, V. Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rat. Psychopharmacology (Berlin) 99:70-74; 1989.
46. Sara, S. J.; Devauges, V. Priming stimulation of locus coeruleus facilitates memory retrieval in the rat. Brain Res. 438:299-303; 1988.
47. Simasko, S. M.; Horita, A. Localization of thyrotropin-releasing hormone (TRH) receptors in the septal nucleus of the rat brain. Brain Res. 296:393-395; 1984.
48. Thai, L. J.; Dokla, C. P. J.; Armstrong, D. M. Nucleus basalis magnocellularis lesions: Lack of biochemical and immunocytochemical recovery and effect of cholinesterase inhibitors on passive avoidance. Behav. Neurosci. 102:852-860; 1988.
49. Warnhoff, M. Simultaneous determination of norepinephrine, dopamine, 5-hydroxytryptamine and their main metabolites in rat brain using high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 307:271-281; 1984.
50. Wenk, G.; Hughey, D.; Boundy, V.; Kim, A.; Walker, L.; Olton, D. Neurotransmitters and memory: Role of cholinergic, serotonergic and noradrenergic systems. Behav. Neurosci. 101:325-332; 1987.
51. Wenk, H.; Bigl, V.; Meyer, U. Cholinergic projections from magnocellular nuclei of the basal forebrain to cortical areas in rats. Brain Res. Rev. 2:295-316; 1980.
52. Yamamoto, M.; Shimizu, M. Effects of a new TRH analogue, YM-14673 on a passive avoidance test as a possible criterion of improvement in cognitive disturbance in rodents. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:262-267; 1988.
53. Yamazaki, N.; Shintani, M.; Saji, Y.; Nagawa, Y. Interaction with cholinergic drugs in reversal of cycloheximide-induced amnesia by thyrotropin-releasing hormone and its analog DN-1417 in mice. Jpn. J. Psychopharmacol. 3:127-136; 1983.
54. Yamazaki, N.; Shintani, M.; Saji, Y.; Nagawa, Y. Effect of TRH and its analog DN-1417 on anoxia-induced amnesia in mice. Jpn. J. Psychopharmacol. 5:1-9; 1985.
55. Yarbrough, G. G. On the neuropharmacology of thyrotropin releasing hormone (TRH). Prog. Neurobiol. 12:291-312; 1979.